Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01875458 · ClinicalTrials.gov registry record
Biomarker Identification in Orthopaedic & Oral Maxillofacial Surgery Subjects to Identify Risks of Bisphosphonate Use
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 314
- Enrollment target
NCT01875458: Completed study, sponsored by University of Pennsylvania.
NCT01875458 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 314 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01875458 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 314 participants
- Enrollment target
Study Summary
Bisphosphonates are drugs that prevent bone loss by blocking the activity of cells that normally resorb bone. The most common examples of these drugs are Boniva and Fosamax. These drugs are available for oral or intravenous dosing and are prescribed at daily, weekly, biweekly, or monthly intervals. Among the many thousands of individuals who currently take these medications, certain individuals experience "atypical" femur fractures preceded by prodromal pain, changes in cortical thickening of bone, or bisphosphonate related osteonecrosis of the jaws (BRONJ). Osteonecrosis of the jaws is defined as exposed bone of the jaws for 8 weeks or more and requires surgical treatment. This study will attempt to identify genomic and rna biomarkers that may play a role in differential metabolism of bisphosphonates or indicate tendency toward the severe adverse events associated with these drugs.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 314 participants |
| Start Date | 2012-04-13 |
| Est. Completion | 2022-10-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01875458
The ClinicalTrials.gov registry entry for NCT01875458 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 314 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01875458 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01875458 about?
NCT01875458 is a clinical study titled "Biomarker Identification in Orthopaedic & Oral Maxillofacial Surgery Subjects to Identify Risks of Bisphosphonate Use". Bisphosphonates are drugs that prevent bone loss by blocking the activity of cells that normally resorb bone. The most common examples of these drugs are Boniva and Fosamax. These drugs are available for oral or intravenous dosing and are prescribed at daily, weekly, biweekly, or monthly intervals. ...
What is the current status of trial NCT01875458?
This trial is currently completed. The enrollment target is 314 participants. The study started on 2012-04-13. Estimated completion is 2022-10-30.
Who is sponsoring clinical trial NCT01875458?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.